BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1192834)

  • 21. Immunochemical characterization of human beta-D-N-acetyl hexosaminidase from normal individuals and patients with Tay-Sachs disease. I. Antigenic differences between hexosaminidase A and hexosaminidase B.
    Bartholomew WR; Rattazzi MC
    Int Arch Allergy Appl Immunol; 1974; 46(4):512-24. PubMed ID: 4132060
    [No Abstract]   [Full Text] [Related]  

  • 22. The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.
    Bladon MT
    Biochem Genet; 1981 Oct; 19(9-10):971-86. PubMed ID: 7332532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Segregation within a family of two mutant alleles for hexosaminidase A.
    Kelly TE; Reynolds LW; O'Brien JS
    Clin Genet; 1976 May; 9(5):540-3. PubMed ID: 1269177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
    Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
    J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies in Tay-Sachs and Sandhoff's diseases. Immunologic and structural properties of hexosaminidase A and hexosaminidase B.
    Beutler E; Srivastava SK
    Isr J Med Sci; 1973; 9(9):1335-7. PubMed ID: 4798071
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y; Kasakura H; Matsumoto M
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract]   [Full Text] [Related]  

  • 27. Hexosaminidase A analysis of various biological fluids by pH inactivation for the identification of Tay-Sachs disease genotypes.
    Saifer A; Perle G
    Prog Clin Biol Res; 1977; 18():227-38. PubMed ID: 23555
    [No Abstract]   [Full Text] [Related]  

  • 28. Tay-Sachs disease in Quebec: evidence for a geographic aggregate in the French-Canadian population and identification of a new retardation syndrome with possible linkage to the Tay-Sachs gene.
    Andermann E; Andermann F; Patry G; Lafontaine R; Geoffroy G; Scriver CR; Wolfe L
    Trans Am Neurol Assoc; 1973; 98():20-4. PubMed ID: 4784938
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of Tay-Sachs by hexosaminidase analysis of urine and tear samples.
    Saifer A; Amoroso J; Perle G
    Adv Exp Med Biol; 1976; 68():339-66. PubMed ID: 7107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tay-Sachs carrier detection by mechanized serum hexosaminidase assay.
    Rosenberg D; Cutler R
    Clin Chim Acta; 1974 Jun; 53(2):247-53. PubMed ID: 4841990
    [No Abstract]   [Full Text] [Related]  

  • 31. N-acetyl-beta-hexosaminidase: role in the degradation of glycosaminoglycans.
    Thompson JN; Stoolmiller AC; Matalon R; Dorfman A
    Science; 1973 Aug; 181(4102):866-7. PubMed ID: 4269276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tay-Sachs disease: a pilot screening program for the detection of the heterozygote in the Charleston Jewish community.
    Rogers JF; Hogan EL; Jorgenson RJ
    South Med J; 1976 Nov; 69(11):1453-5. PubMed ID: 1019641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes.
    Saifer A; Perle G
    Clin Chem; 1974 May; 20(5):538-43. PubMed ID: 4826945
    [No Abstract]   [Full Text] [Related]  

  • 34. Tay-Sachs disease: interrelation of hexosaminidases A and B.
    Robinson D; Carroll M
    Lancet; 1972 Feb; 1(7745):322-3. PubMed ID: 4109961
    [No Abstract]   [Full Text] [Related]  

  • 35. Gangliosidosis with total hexosaminidase deficiency: clinical, biochemical and ultrastructural studies and comparison with conventional cases of Tay-Sachs disease.
    Fontaine G; Résibois A; Tondeur M; Jonniaux G; Farriaux JP; Voet W; Maillard E; Loeb H
    Acta Neuropathol; 1973 Jan; 23(2):118-32. PubMed ID: 4349527
    [No Abstract]   [Full Text] [Related]  

  • 36. Complementation after fusion of Sandhoff- and Tay-Sachs fibroblasts.
    Ropers HH; Grzeschik KH; Bühler E
    Humangenetik; 1975; 26(2):117-21. PubMed ID: 803466
    [No Abstract]   [Full Text] [Related]  

  • 37. Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease.
    Srivastava SK; Beutler E
    Nature; 1973 Feb; 241(5390):463. PubMed ID: 4122341
    [No Abstract]   [Full Text] [Related]  

  • 38. NN'-diacetylchitobiase activity in Tay-Sachs disease and Sandhoff's disease.
    Stirling JL
    Biochem J; 1974 Aug; 141(2):597-9. PubMed ID: 4455225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcellular fractions from Tay-Sachs brains: ganglioside, lipid, and protein composition and hexosaminidase activities.
    Kornguth S; Wannamaker B; Kolodny E; Geison R; Scott G; O'Brien JF
    J Neurol Sci; 1974 Jul; 22(3):383-406. PubMed ID: 4857837
    [No Abstract]   [Full Text] [Related]  

  • 40. Newer aspects of some interesting lipid storage diseases: Tay-Sachs and Gaucher's diseases.
    Beutler E
    West J Med; 1977 Jan; 126(1):46-54. PubMed ID: 831367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.